Catalyst Wire Dossier Catalyst Wire Dossier

Sunobinop

· Imbrium Therapeutics
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Sunobinop, covering 2025-07-23 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder [Phase 2]

See pricing